Earl J. Brewer Award

This award recognizes a training fellow who, in his/her first two years of fellowship, has distinguished him or herself in an area of clinical research. Any rheumatology fellow who is training at an accredited training program in the US or Canada is eligible in the beginning of his or her third year of fellowship. The Executive Committee members will review pediatric rheumatology abstracts submitted to the American College of Rheumatology (ACR) Annual Meeting. The award recipient will receive a certificate, and an honorarium presented during the pediatric rheumatology business meeting held during the ACR annual meeting.

Award Recipients

2025	Marianne Kerski, MD	Chronic JDM Plasma Proteomic Signature Reflects Inflammation from Immune and Tissue-resident Muscle and Skin
2025	Shannon O’Connor, MD, PhD	Single Nuclei Multiome of JDM Muscle Biopsies Reveals Novel Upregulation of Inflammator and Vascular Pathways”
2025	Eileen Rife, MD, MPH	Krebs von den Lunben-6 (KL-6) as a Potential Diagnositic Biomarker of Lung Disease in Pediatric Systemic Juvenile Idiopathic Arthritis: Preliminary Findings from a Multisite US Cohort
2024	No award given
2023	Nicholas McClellan, DO	Differences in Nailfold Capillary Morphology Distinguish Juvenile Dermatomyositis Patients That Are Myositis-Specific Autoantibody Positive
2022	Christine Wang, MD, FAAP	Renal Response Outcomes of NorthAmerican Youth with Proliferative Lupus Nephritis Treated with the EuroLupus versusNIH Cyclophosphamide Dosing Regimen
2021	Daniel Reiff, MD, FAAP	Where Do MultisystemInflammatory Syndrome in Children (MIS-C) and Pediatric COVID-19 Fit Under theCytokine Storm Syndrome Umbrella
2021	Meghan McPherson, MD	Can We Assess Disability in JuvenileIdiopathic Arthritis with Two Simple Questions? Results from the CAPRI Registry
2020	Najla Aljaberi, MBBS	Renal Activity Index for Lupus NephritisDistinguishes Active Renal Disease Among Childhood Systemic Lupus Erythematosus Patients
2019	Anne McHugh, MD	Profiling Behavioral and PsychologicalSymptoms in Children with Spondyloarthritis and Polyarthritis
2019	Shima Yasin, MD	Free Interlukin-18: A New PromisingBiomarkers for Systemic Juvenile Idiopathic Arthritis and Macrophage activationSyndrome
2018	Sara Sabbagh, MD	Association of Anti-Ro52 Autoantibodies with Interstitial Lung Disease and More Severe Disease Manifestations in Juvenile Idiopathic Inflammatory Myopathies
2018	Paul Tsoukas, MD	Abortive Viral Infection Becomes MacrophageActivation Syndrome in Mice with Chronically Elevated Interleukin-18: Evidence for Synergy with Cytotoxic Impairment
2017	Shima Yasin, MD	Serum Interleukin 18 As a Biomarker for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome and Use of Recombinant Human IL-18 BP in a Patient with Refractory Disease
2017	Cynthia Manos, MD	Risk Factors for Arthritis and the Development of Comorbid Cardiovascular and Metabolic Disease in Children with Psoriasis
2016	Tiphanie Vogel, MD	Mechanism of STAT3 Gain-of-Function in a Patient with JIA
2015	Jessica Turnier, MD	Highly Elevated S100A8/A9 and S100A12 Levels May Distinguish Systemic Juvenile Idiopathic Arthritis Patients with New Onset Disease and Subclinical Macrophage Activation Syndrome
2014	Hanna Kim, MD	Validation of a Novel IFN-Regulated Gene Score As Biomarker in Chronic Atypical Neutrophilic Dermatosis with Lipdoystrophy and Elevated Temperature (CANDLE) Patients on Baricitinib, a Janus Kinase ½ Inhibitor, a Proof of Concept
2013	Julie Barsalou, MD	“The Effect of Maternal Antimalarial Intake During Pregnancy On The Risk Of Neonatal Lupus
2012	Julisa Patel, MD	Effects of Nelfinavir on Anti-dsDNA Antibody Binding and Pro-Inflammatory Cytokine Gene Expression”
2011	Mark Goerlik, MD	Serum Follistatin-Like Protein 1 is Elevated in Systemic Juvenile Idiopathic Arthritis and Is a Biomarker for Macrophage Activation Syndrome
2010	Keith Sikora, MD	Specific Subgroup of New-Onset Systemic Juvenile Idiopathic Arthritis without Overt Macrophage Activation Syndrome Shares Similar Gene Expression Signature with a Distinct Subset of Familial Hemophagocytic Lymphohistiocytosis
2009	Lena Das, MD	Candidate Urinary Biomarkers May Predict Histological Features On Lupus Nephritis (LN) Biopsy
2008	Claas Hinze, MD	Neutrophil Gelatinase Associated Lipocalin (NGAL) in Urine Predicts the Course of Nephritis in Pediatric Systemic Lupus Erythematosus
2006	Edward Behrens, MD	Occult Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
2005	Bita Arabshahi, MD	Temporomandibular Joint (TMJ) Arthritis: Incidence, Diagnosis, and Predictors of Active Disease in Juvenile Idiopathic Arthritis
2004	Jennifer Weiss, MD	Pediatric Systemic Lupus Erythematosus: Change in SELENA SLEDAI Score with Disease Flare
2003	Susanne Benseler, MD	Primary CNS Vasculitis in Children
2002	Anne Marie Brescia, MD	Prolonged Synovitis in Pediatric Lyme Disease: A Study on Clinical and Laboratory Predictors
2001	Deborah Levy Miller, MD	Thromboembolism in Pediatric Systemic Lupus Erythematosus (SLE) Patients with Antiphospholipid Antibodies

Last Updated

09/24/2026

Source

American Academy of Pediatrics